Use of AI in Drug Development Raises Novel Patentability Questions

With pharmaceutical companies and inventors increasingly using artificial intelligence (AI) for drug discovery and development, legal challenges to the validity of patents on drugs that were developed with assistance from AI may start emerging in the coming years, health care and intellectual property lawyers told The Capitol Forum

Published on Jun 17, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.